先天免疫系统
肿瘤微环境
趋化因子
免疫系统
先天性淋巴细胞
免疫疗法
免疫学
生物
髓源性抑制细胞
CCL18型
癌变
癌症研究
癌症
抑制器
遗传学
作者
Chenglin Lu,Ying Liu,Nasra Mohamoud Ali,Bin Zhang,Xiaonan Cui
标识
DOI:10.3389/fimmu.2022.1039260
摘要
Innate immune cells in the tumor microenvironment (TME) mainly include macrophages, neutrophils, natural killer cells, dendritic cells and bone marrow derived suppressor cells. They play an anti-tumor or pro-tumor role by secreting various cytokines, chemokines and other factors, and determine the occurrence and development of tumors. Comprehending the role of innate immune cells in tumorigenesis and progression can help improve therapeutic approaches targeting innate immune cells in the TME, increasing the likelihood of favorable prognosis. In this review, we discussed the cell biology of innate immune cells, their role in tumorigenesis and development, and the current status of innate immune cell-based immunotherapy, in order to provide an overview for future research lines and clinical trials.
科研通智能强力驱动
Strongly Powered by AbleSci AI